US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Hikma Pharmaceuticals plc.

43.75

-0.7050-1.59%

Volume:424.00

Turnover:18.52K

Market Cap:4.85B

PE:13.59

High:43.75

Open:43.75

Low:43.75

Close:44.46

52wk High:58.00

52wk Low:39.93

Shares:110.87M

Float Shares:77.66M

Volume Ratio:0.51

T/O Rate:0.00%

Dividend:1.68

Dividend Rate:3.84%

EPS(TTM):3.22

EPS(LYR):3.24

ROE:15.38%

ROA:6.97%

PB:1.91

PE(LYR):13.49

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Hikma Pharmaceuticals plc.

Exchange:

PINK LIMITED

Establishment Date:

1978

Employees:

9500

Office Location:

1 New Burlington Place,London,United Kingdom

Website:

http://www.hikma.com

Zip Code:

W1S 2HR

Phone:

44 20 7399 2760

Fax:

- -

Introduction:

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms in North America, the Middle East, North Africa, and Europe. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. The company was founded in 1978 and is headquartered in London, the United Kingdom.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/HKMPY/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HKMPY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HKMPY\",,,,,undefined,":{"symbol":"HKMPY","market":"US","secType":"STK","nameCN":"Hikma Pharmaceuticals plc.","latestPrice":43.75,"timestamp":1771879873880,"preClose":44.455,"halted":0,"volume":424,"delay":15,"changeRate":-0.015858733550781653,"floatShares":77664105,"shares":110873787,"eps":3.22,"marketStatus":"Post-Mkt","change":-0.705,"latestTime":"02-23 15:51:13 EST Delay","open":43.75,"high":43.75,"low":43.75,"amount":18520.4228,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":3.22,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1771894800000},"marketStatusCode":4,"adr":0,"adrRate":2,"exchange":"PINK LIMITED","adjPreClose":44.455,"volumeRatio":0.514313},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HKMPY\",,,,,undefined,":{"symbol":"HKMPY","floatShares":77664105,"roa":"6.97%","roe":"15.38%","lyrEps":3.243976,"volumeRatio":0.514313,"shares":110873787,"dividePrice":1.68,"high":43.75,"amplitude":0,"preClose":44.455,"low":43.75,"week52Low":39.93,"pbRate":"1.91","psRate":"1.51","week52High":58,"institutionHeld":0,"latestPrice":43.75,"eps":3.22,"divideRate":0.0384,"volume":424,"delay":15,"ttmEps":3.22,"open":43.75,"prevYearClose":41.925,"prevWeekClose":44.455,"prevMonthClose":42.375,"prevQuarterClose":41.925,"fiveDayClose":43.145,"twentyDayClose":42.6,"sixtyDayClose":42.6115},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HKMPY\",params:#limit:5,,,undefined,":[{"date":"2025-08-18","symbol":"HKMPY","amount":0.72,"announcedDate":"2025-08-08","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-08-18","defaultRemindTime":1755523800000,"name":"Hikma Pharmaceuticals plc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-29","payableDate":"2025-08-18","currency":"USD","dateTimestamp":1755489600000,"payDate":"2025-09-29"},{"date":"2025-03-21","symbol":"HKMPY","amount":0.96,"announcedDate":"2025-02-28","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-21","defaultRemindTime":1742563800000,"name":"Hikma Pharmaceuticals plc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-12","payableDate":"2025-03-21","currency":"USD","dateTimestamp":1742529600000,"payDate":"2025-05-12"},{"market":"US","date":"2025-02-26","symbol":"HKMPY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1740546000000,"reportTimeType":"","actualEps":null},{"date":"2024-08-19","symbol":"HKMPY","amount":0.64,"announcedDate":"2024-08-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-08-19","defaultRemindTime":1724074200000,"name":"Hikma Pharmaceuticals plc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-30","payableDate":"2024-08-19","currency":"USD","dateTimestamp":1724040000000,"payDate":"2024-09-30"},{"date":"2024-03-21","symbol":"HKMPY","amount":0.94,"announcedDate":"2024-03-05","type":"dividend","market":"US","newRecordDate":"2024-03-22","defaultRemindTime":1711027800000,"name":"Hikma Pharmaceuticals plc.","recordDate":"2024-05-13","payableDate":"2024-03-22","currency":"USD","dateTimestamp":1710993600000,"payDate":"2024-05-13"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HKMPY\",market:\"US\",,,undefined,":[{"executeDate":"2016-04-06","recordDate":"2016-04-08","paymentDate":"2016-05-31","value":0.4,"currency":"USD"},{"executeDate":"2016-09-01","recordDate":"2016-09-06","paymentDate":"2016-10-11","value":0.2,"currency":"USD"},{"executeDate":"2018-08-24","recordDate":"2018-08-27","paymentDate":"2018-10-01","value":0.22,"currency":"USD"},{"executeDate":"2019-04-04","recordDate":"2019-04-05","paymentDate":"2019-06-03","value":0.5,"currency":"USD"},{"executeDate":"2019-08-22","recordDate":"2019-08-23","paymentDate":"2019-10-03","value":0.26,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HKMPY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3846,"buy":0.4615,"hold":0.0769,"sell":0.0769,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4615,"analysts":13,"updateTime":1768626000000},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":23049465,"yearFounded":1978,"employeeNum":9500,"address":"1 New Burlington Place,London,United Kingdom","zipCode":"W1S 2HR","officePhone":"44 20 7399 2760"},"stockCompanyDetail":{"websiteUrl":"http://www.hikma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0.1507},{"period":"6month","weight":0},{"period":"1year","weight":0.0777},{"period":"ytd","weight":0.0847}],"description":"Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms in North America, the Middle East, North Africa, and Europe. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. The company was founded in 1978 and is headquartered in London, the United Kingdom.","exchange":"PINK LIMITED","name":"Hikma Pharmaceuticals plc.","nameEN":"Hikma Pharmaceuticals plc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"HKMPY\",market:\"US\",,,undefined,":null}}